sequenom

Spanish MaterniT 21 PLUS core patient brochure_Rep-1053-v1-0217

• Email

Spanish MaterniT 21 PLUS ESS patient brochure_Rep-1054-v1-0217

• Email

Expanding Noninvasive Prenatal Testing (NIPT) to Average Risk: MaterniT® 21 PLUS Performance in the Average Risk vs. High Risk Population

• Email

Optimized Detection of 22q11.2 Deletions Using Whole Genome Sequencing

• Email

Five years of precision – cfDNA as a case example

• Email

Success of NIPT based on Maternal Weight and Gestational Age

• Email

MaterniT 21® PLUS provider brochure

• Email

Abnormal ultrasound and increased yield of abnormal results with genome-wide cfDNA analysis

• Email

Expanding noninvasive prenatal testing (NIPT) for screening of unbalanced translocations

• Email

Genome wide detection of chromosomal gains and losses greater than 7Mb by cfDNA analysis

• Email

Clinical experience of trisomy 16 and 22, and microdeletion detection by noninvasive prenatal testing (NIPT)

• Email

Automated genomic interpretation of sub-chromosomal fetal copy number variation by sequencing circulating cell-free DNA from maternal plasma

• Email

Circulating cell-free DNA screening for fetal aneuploidy- the Newton-Wellesley Hospital Maternal Fetal Medicine experience

• Email

Identification of 22q11 microdeletions by noninvasive prenatal testing (NIPT) - the clinical experience

• Email

Karyotype-level noninvasive prenatal testing by sequencing of circulating cell-free DNA from maternal plasma

• Email

Noninvasive prenatal testing aids in detecting parental balanced translocation and highlights limitations of karyotyping

• Email

Rings and things- Noninvasive prenatal testing¹s unique view of the biology and embryology behind chromosomal ring formation and segregation

• Email

Two cases of Wolf-Hirshhorn syndrome detected by noninvasive prenatal testing (NIPT)

• Email

HerediT CF provider sheet

• Email

MaterniT GENOME Provider Brochure Aug 2015

• Email